Quick Answer
ARTELO BIOSCIENCES, INC. reported Earnings Per Share Diluted of $12.52 (loss) per share for the year ending 2025.
- ARTELO BIOSCIENCES, INC. showed an increase of +31.6% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from ARTELO BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2018 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $0.07 (loss) per share | Q2 2018: $0.36 (loss) per share | Q4 2018: $0.32 (loss) per share | Q1 2019: $0.40 (loss) per share | Q2 2019: $0.40 (loss) per share | Q4 2019: $0.40 (loss) per share | Q1 2020: $0.40 (loss) per share | Q3 2023: $0.83 (loss) per share | Q1 2024: $0.78 (loss) per share | Q2 2024: $4.52 (loss) per share | Q3 2024: $2.10 (loss) per share | Q1 2025: $0.72 (loss) per share | Q2 2025: $5.61 (loss) per share | Q3 2025: $3.97 (loss) per share.
- Over the full 5 years of available data (2018 to 2025), ARTELO BIOSCIENCES, INC.'s Earnings Per Share Diluted has declined by 580.4%.
- Historical annual values: Fiscal year 2025: $12.52 (loss) per share | Fiscal year 2024: $18.30 (loss) per share | Fiscal year 2023: $3.14 (loss) per share | Fiscal year 2019: $1.46 (loss) per share | Fiscal year 2018: $1.84 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: